Comorbidities against Quality Control of VKA Therapy in Non-Valvular Atrial Fibrillation: A French National Cross-Sectional Study

BACKGROUND: Given the prevalence of non-valvular atrial fibrillation in the geriatric population, thromboembolic prevention by means of vitamin K antagonists (VKA) is one of the most frequent daily concerns of practitioners. The effectiveness and safety of treatment with VKA correlates directly with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouaud, Agnes, Hanon, Olivier, Boureau, Anne-Sophie, Chapelet, Guillaume Gilles, de Decker, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366229/
https://www.ncbi.nlm.nih.gov/pubmed/25789771
http://dx.doi.org/10.1371/journal.pone.0119043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366229/
https://www.ncbi.nlm.nih.gov/pubmed/25789771
http://dx.doi.org/10.1371/journal.pone.0119043

Ejemplares similares